Cancer Research UK-MedImmune Alliance Laboratory: An innovative alliance model

2.30PM, Strategic Alliance Management Congress, Lisbon
Julie Little, Strategic Alliance Executive, Commercial Partnerships, CRUK

Our standalone laboratory brings together Cancer Research UK biology expertise with MedImmune world-leading antibody engineering technology. 
In a very collaborative environment, we work closely with academic scientists to access novel biology and targets to help translate their discoveries into cancer patients benefit.
Julie will describe how the laboratory came about and how it operates, the value that this alliance brings as well as lessons learnt in these past three years since its inception.